mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence

by Stoppel, David C, McCamphill, Patrick K, Senter, Rebecca K, Heynen, Arnold J, Bear, Mark F
Published 2021

ß-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X

by Auerbach, Benjamin D., Lefkowitz, Robert J., Stoppel, Laura Jane, Senter, Rebecca K, Preza, Anthony R., Bear, Mark
Published 2017

β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X

by Auerbach, Benjamin D., Lefkowitz, Robert J., Stoppel, Laura Jane, Senter, Rebecca K, Preza, Anthony R., Bear, Mark
Published 2017

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

by McCamphill, Patrick K., Stoppel, Laura J., Senter, Rebecca K., Lewis, Michael C., Heynen, Arnold J., Stoppel, David C., Sridhar, Vinay, Collins, Katie A., Shi, Xi, Pan, Jen Q., Madison, Jon, Cottrell, Jeffrey R., Huber, Kimberly M., Scolnick, Edward M., Holson, Edward B., Wagner, Florence F., Bear, Mark F.
Published 2022

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

by McCamphill, Patrick K, Stoppel, Laura J, Senter, Rebecca K, Lewis, Michael C, Heynen, Arnold J, Stoppel, David C, Sridhar, Vinay, Collins, Katie A, Shi, Xi, Pan, Jen Q, Madison, Jon, Cottrell, Jeffrey R, Huber, Kimberly M, Scolnick, Edward M, Holson, Edward B, Wagner, Florence F, Bear, Mark F
Published 2021